Civic Intelligence

Globalization of Pharmaceutics Education Network Inc.

990 • Fiscal year 2012 • EIN 48-1209067

Jan 01, 2012 to Dec 31, 2012

Lawrence, KS
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

53rd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Liabilities / Revenue

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Net Margin

72nd percentile

15%

Higher net margin than 72% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

66th percentile

12%

Faster asset growth than 66% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Annualized from 2011 to 2012

Revenue Growth

99th percentile

1234%

Faster revenue growth than 99% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Annualized from 2011 to 2012

Assets

Up

$411,593

Up $43,150 (+12%) from 2011

Net Assets

Up

$411,593

Up $43,150 (+12%) from 2011

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

Up

$288,333

Up $266,718 (+1234%) from 2011

Expenses

Up

$245,183

Up $242,078 (+7796%) from 2011

Net Income

Up

$43,150

Up $24,640 (+133%) from 2011

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2010: $455,485Liabilities 2010: $105,552Net Assets 2010: $349,9332010Assets 2011: $368,443Net Assets 2011: $368,4432011Assets 2012: $411,593Liabilities 2012: $0Net Assets 2012: $411,5932012Assets 2013: $390,961Net Assets 2013: $390,9612013Assets 2014: $449,888Liabilities 2014: $0Net Assets 2014: $449,8882014Assets 2015: $455,373Net Assets 2015: $455,3732015Assets 2016: $543,790Liabilities 2016: $0Net Assets 2016: $543,7902016Assets 2017: $504,832Liabilities 2017: $0Net Assets 2017: $504,8322017Assets 2018: $659,163Liabilities 2018: $0Net Assets 2018: $659,1632018Assets 2019: $667,538Liabilities 2019: $0Net Assets 2019: $667,5382019Assets 2020: $769,029Liabilities 2020: $0Net Assets 2020: $769,0292020Assets 2021: $776,276Liabilities 2021: $0Net Assets 2021: $776,2762021Assets 2022: $754,565Liabilities 2022: $0Net Assets 2022: $754,5652022Assets 2023: $780,367Liabilities 2023: $0Net Assets 2023: $780,3672023Assets 2024: $643,910Liabilities 2024: $0Net Assets 2024: $643,9102024

Highlighted filing

2012

Assets$411,593
Liabilities$0
Net Assets$411,593

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$400K$200K$0-$200KExpenses 2010: $175,1352010Revenue 2011: $21,615Expenses 2011: $3,105Net Income 2011: $18,5102011Revenue 2012: $288,333Expenses 2012: $245,183Net Income 2012: $43,1502012Revenue 2013: $10,723Expenses 2013: $31,355Net Income 2013: -$20,6322013Revenue 2014: $217,852Expenses 2014: $158,925Net Income 2014: $58,9272014Revenue 2015: $30,000Expenses 2015: $24,515Net Income 2015: $5,4852015Revenue 2016: $247,380Expenses 2016: $158,963Net Income 2016: $88,4172016Revenue 2017: $5,870Expenses 2017: $44,828Net Income 2017: -$38,9582017Revenue 2018: $225,686Expenses 2018: $69,687Net Income 2018: $155,9992018Revenue 2019: $31,851Expenses 2019: $23,306Net Income 2019: $8,5452019Revenue 2020: $142,824Expenses 2020: $40,238Net Income 2020: $102,5862020Revenue 2021: $19,694Expenses 2021: $11,579Net Income 2021: $8,1152021Revenue 2022: $121,825Expenses 2022: $142,254Net Income 2022: -$20,4292022Revenue 2023: $42,465Expenses 2023: $16,948Net Income 2023: $25,5172023Revenue 2024: $76,421Expenses 2024: $213,137Net Income 2024: -$136,7162024

Highlighted filing

2012

Revenue$288,333
Expenses$245,183
Net Income$43,150
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

To foster and facilitate international scientific exchange in the pharmaceutical sciences.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$6.44$0.00$6.44$0.76$2.13$1.37
2023Detailed filing. Detailed filing data is available for this year.$7.80$0.00$7.80$0.42$0.17$0.26
2022Detailed filing. Detailed filing data is available for this year.$7.55$0.00$7.55$1.22$1.42$0.20
2021Detailed filing. Detailed filing data is available for this year.$7.76$0.00$7.76$0.20$0.12$0.08
2020Detailed filing. Detailed filing data is available for this year.$7.69$0.00$7.69$1.43$0.40$1.03
2019Detailed filing. Detailed filing data is available for this year.$6.68$0.00$6.68$0.32$0.23$0.09
2018Detailed filing. Detailed filing data is available for this year.$6.59$0.00$6.59$2.26$0.70$1.56
2017Detailed filing. Detailed filing data is available for this year.$5.05$0.00$5.05$0.06$0.45$0.39
2016Detailed filing. Detailed filing data is available for this year.$5.44$0.00$5.44$2.47$1.59$0.88
2015Detailed filing. Detailed filing data is available for this year.$4.55$4.55$0.30$0.25$0.05
2014Detailed filing. Detailed filing data is available for this year.$4.50$0.00$4.50$2.18$1.59$0.59
2013Detailed filing. Detailed filing data is available for this year.$3.91$3.91$0.11$0.31$0.21
2012Summary only. Only limited summary data is available for this year.$4.12$0.00$4.12$2.88$2.45$0.43
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.68$3.68$0.22$0.03$0.19
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.55$1.06$3.50$1.75